Bluejay Diagnostics Inc
BJDX
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.02M
Close$
$11.23
275.7% upside
Current Fair Value
275.7% upsideUndervalued by 275.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.02 Million |
|---|---|
| Enterprise Value | $-1,564,632.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-15.25 |
| Beta | 0.82 |
| Outstanding Shares | 449,043 |
Return
| Return on Equity | -165.10% |
|---|---|
| Return on Assets | -123.30% |
| Return on Invested Capital | 45.14% |
Valuation & Multiples
| P/E Ratio | -0.27 |
|---|---|
| PEG | -9.3 |
| Price to Sales | - |
| Price to Book Ratio | 0.33 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -0.83 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -0.06 |
| Debt to Equity | 0.02 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 13, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
August 19, 2026
EPS Estimate
$-3520.00
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 13.10%▲ 3.72% |
|---|---|
| Total Invested | $108,244▼ 3.60% |
| Investors Holding | 6▼ 2.00% |
ESG Score
No data